Health Condition 1: C159- Malignant neoplasm of esophagus, unspecified Health Condition 2: C169- Malignant neoplasm of stomach, unspecified Health Condition 3: C179- Malignant neoplasm of small intestine, unspecified Health Condition 4: C189- Malignant neoplasm of colon, unspecified Health Condition 5: C19- Malignant neoplasm of rectosigmoidjunction Health Condition 6: C20- Malignant neoplasm of rectum Health Condition 7: C218- Malignant neoplasm of overlappingsites of rectum, anus and anal cana
Conditions
Interventions
Intervention1: Enteral immunonutrition (Maxvida advance formula), Probiotic- Sporolac satchet: Formula- 3scoops/day in water for 5days in preoperative period and 4 days in postoperative period. Sporol
Sponsors
Dr Reshmi Suresh
Eligibility
Inclusion criteria
Inclusion criteria: 1.All cases of gastrointestinal malignancies undergoing curative elective surgeries in the department of surgical oncology, AIIMS Bhubaneswar. 2.Eastern Cooperative Oncology Group score less than 3. 3.Patients willing to consent for participating in the study.
Exclusion criteria
Exclusion criteria: 1.Gastric outlet obstruction, intestinal obstruction undergoing emergency surgery. 2.Sepsis 3.Renal failure and hepatic failure 4.Psychiatric illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of postoperative infectious complicationsTimepoint: 30 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Anemia, hypoalbuminemia, inflammatory status.Timepoint: 2 and 4th day of postoperative period;non infectious complications, duration of postoperative hospital stay, recovery.Timepoint: 30 days | — |
Countries
India
Contacts
Public ContactDr Reshmi Suresh
All India Institute of Medical Sciences, Bhubaneswar
Outcome results
None listed